Development of a long‐acting relaxin analogue, LY3540378, for treatment of chronic heart failure.Published in:British Journal of Pharmacology, 2023, v. 180, n. 15, p. 1965, doi. 10.1111/bph.16055By:Verdino, Petra;Lee, Stacey L.;Cooper, Fariba N.;Cottle, Steven R.;Grealish, Patrick F.;Hu, Charlie C.;Meyer, Catalina M.;Lin, Joanne;Copeland, Victoria;Porter, Gina;Schroeder, Richard L.;Thompson, Tyran D.;Porras, Leah L.;Dey, Asim;Zhang, Hong Y.;Beebe, Emily C.;Matkovich, Scot J.;Coskun, Tamer;Balciunas, Aldona M.;Ferrante, AndreaPublication type:Article